![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Centaur Pharmaceuticals Private Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Tetrazepam, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2011-186 - Rev 01
This Chemical Type CEP, issued on June 08, 2017, remains in force until January 26, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1738 associated with this CEP further emphasizes